Abstract
Efficacy in HIV clinical trials is measured by changes in HIV RNA levels over time as well as the proportion of subjects with HIV RNA levels below an assay’s threshold of reliable quantification at a single time point. Missing data arise naturally due to missed visits and premature discontinuations of treatment. The available data are then analyzed using repeated measures models and univariate comparisons of proportions, assuming missing data occur at random or considering missing values as treatment failures (worst case scenario). These and other methods recently proposed by regulatory authorities are presented along with alternative approaches. Advantages and disadvantages of each method are discussed. Data from a recent comparison of ’ standard-of-care’ triple combination regimens are used for illustration.
Similar content being viewed by others
References
Myers WR. Handling missing data in clinical trials: An overview. Drug Inf J. 2000;34:525–533.
Little RJA, Rubin DB. Statistical Analysis with Missing Data, New York, NY: Wiley; 1987.
Murray J. Guidance for Industry—Clinical Considerations for Accelerated and Traditional Approval for Antiviral Drugs Using Plasma Viral RNA Measurements. Rockville, MD: US Food and Drug Administration; 1999.
Committee for Proprietary Medicinal Products (CPMP). Points to consider in the Assessment of an Anti-HIV Medicinal Product. London, UK: The European Agency for the Evaluation of Medicinal Products; 2000.
Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics. 1982;38:963–974.
Littell RC, Milliken GA, Stroup WW, Wolfinger RD. SAS System for Mixed Models. Cary, NC: SAS Institute Inc; 1996.
Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13–22.
Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York, NY: Wiley; 1987.
Rubin DB. Multiple imputation after 18+ years (with discussion). J Am Stat Assoc. 1996;91:473–489.
Schafer JL. Analysis of Incomplete Multivariate Data. New York, NY: Wiley; 1997.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kelleher, T., Thiry, A., Wilber, R. et al. Missing Data Methods in HIV Clinical Trials: Regulatory Guidance And Alternative Approaches. Ther Innov Regul Sci 35, 1363–1371 (2001). https://doi.org/10.1177/009286150103500432
Published:
Issue Date:
DOI: https://doi.org/10.1177/009286150103500432